Synjardy 1000 mg/1

Synjardy 1000 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Synjardy 1000 mg/1 tablets are used to help manage type 2 diabetes in adults. This combination medication works by improving insulin sensitivity and reducing glucose absorption in the kidneys. It is often prescribed alongside diet and exercise to help control blood sugar levels.

Common effects of Synjardy 1000 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users may also experience dizziness or headache. These effects vary and are not experienced by everyone.

Synjardy 1000 mg/1 tablets should be used with caution in individuals with kidney problems or a history of pancreatitis. It is important to follow your healthcare provider's advice regarding diet, exercise, and regular blood sugar monitoring.

Synjardy 1000 mg/1 tablets may interact with certain medications, including diuretics, blood pressure medications, and other diabetes treatments. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.